1-4 of 4
Didier Adiko
Close
Sort by
Journal Articles

In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present from the Diagnosis in Tiny Undetectable Subclones

Herve Avet-Loiseau, Romain Lannes, Aurore Perrot, Céline Mazzotti, Marion Divoux, Titouan Cazaubiel, Xavier Leleu, Anaïs Schavgoulidze, Marie-Lorraine Chretien, Salomon Manier, Didier Adiko, Frédérique Orsini-Piocelle, Francois Lifermann, Sabine Brechignac, Lauris Gastaud, Didier Bouscary, Magaret Macro, Mohamad Mohty, Nikhil C. Munshi, Jill Corre
Journal: Blood
Blood (2021) 138 (Supplement 1): 77.
https://doi.org/10.1182/blood-2021-146869
Published: 2021
Journal Articles

Clinical Spectrum, Long-Term Outcomes and Predictors of Relapse after Imatinib Discontinuation in FIP1L1-Pdgfra-Associated Chronic Eosinophilic Leukemia: Data from 150 Patients

Julien Rohmer, MD, Matthieu Groh, MD, Julie Trichereau, Kewin Panel, Claude Preudhomme, PharmD, PhD, Fanny Legrand, PhD PharmD, Felix Ackermann, MD, Amélie Couteau-Chardon, MD, Mikael Ebbo, MD PhD, Olivier Fain, MD, Lionel Galicier, MD, Mohamed Hamidou, Mathilde Hunault, MD PhD, Etienne Lengline, MD, Catherine Mohr, MD, Franck E Nicolini, MD PhD, Jerome Rey, Louis Terriou, MD, Chafika Morati Hafsaoui, MD, Suzanne Tavitian, MD, Irene Machelart, Katayoun Jondeau, MD, Bertrand Arnulf, Jean-Christophe Ianotto, MD PhD, Jean-Marc Zini, Viviane Dubruille, MD, Francoise Huguet, MD, Borhane Slama, MD, Fabrice Jardin, Didier Adiko, Elise Toussaint, MD, Aurelien Guffroy, MD PhD, Faustine Lhomme, MD PhD, Nathalie Grardel, Cyrielle Gesquieres, Guillaume Lefèvre, MD PhD, Jean Emmanuel Kahn, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 840.
https://doi.org/10.1182/blood-2019-130009
Published: 2019
Journal Articles

ELN 2013 Response Status Criteria: Relevance For De Novo imatinib Chronic Phase Chronic Myeloid Leukemia Patients?

Gabriel Etienne, MD, PHD, Stephanie Dulucq, MD, Axelle Lascaux, MD, Anna Schmitt, MD, Audrey Bidet, Marie-Pierre Fort, Eric Lippert, Caroline Bureau, Didier Adiko, MD, Sandrine Hayette, Josy Reiffers, MD, Franck E. Nicolini, MD PhD, Francois-Xavier Mahon, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4029.
https://doi.org/10.1182/blood.V122.21.4029.4029
Published: 2013
Journal Articles

Achieving a Complete Molecular Remission Under Imatinib Therapy Is Associated with a Better Outcome in Chronic Phase Chronic Myeloid Leukaemia Patients On Imatinib Frontline Therapy

Gabriel Etienne, MD, PHD, Nicolini E Nicolini, MD, PhD, Stéphanie Dulucq, Anna Schmitt, Sandrine Hayette, Éric Lippert, MD, PhD, Isabelle Tigaud, MD, Stephane Morisset, Stat., Caroline Bureau, Didier Adiko, Gerald Marit, MD, Josy Reiffers, MD, Francois-Xavier Mahon, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3754.
https://doi.org/10.1182/blood.V120.21.3754.3754
Published: 2012